Reaction Details |
| Report a problem with these data |
Target | Serine/threonine-protein kinase PLK1 |
---|
Ligand | BDBM50263317 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_535435 (CHEMBL985261) |
---|
IC50 | 23±n/a nM |
---|
Citation | Wang, HY; Cao, ZX; Li, LL; Jiang, PD; Zhao, YL; Luo, SD; Yang, L; Wei, YQ; Yang, SY Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors. Bioorg Med Chem Lett18:4972-7 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Serine/threonine-protein kinase PLK1 |
---|
Name: | Serine/threonine-protein kinase PLK1 |
Synonyms: | PLK | PLK-1 | PLK1 | PLK1_HUMAN | Polo-like kinase 1 (PlK1) | Polo-like kinase 1 (Plk-1) | STPK13 | Serine/threonine-protein kinase (PLK1) | Serine/threonine-protein kinase 13 | polo-like kinase |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 68277.16 |
Organism: | Homo sapiens (Human) |
Description: | P53350 |
Residue: | 603 |
Sequence: | MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLG
KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF
EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG
NLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI
MYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL
NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNKGLENPLPERPREKEE
PVVRETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDK
YGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLK
YFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTK
LILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRL
KAS
|
|
|
BDBM50263317 |
---|
n/a |
---|
Name | BDBM50263317 |
Synonyms: | (S)-allyl 2-cyano-2-(3-ethyl-4-oxo-5-((4-(3-(2-(pyrrolidin-1-yl)ethyl)ureido)phenylamino)methyl)thiazolidin-2-ylidene)acetate | CHEMBL477407 |
Type | Small organic molecule |
Emp. Form. | C25H32N6O4S |
Mol. Mass. | 512.624 |
SMILES | CCN1C(=O)[C@H](CNc2ccc(NC(=O)NCCN3CCCC3)cc2)S\C1=C(\C#N)C(=O)OCC=C |r| |
Structure |
|